GO:0002384 hepatic immune response: Immune Regulation in the Liver, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002384 hepatic immune response is defined as an immune response taking place in the liver, encompassing innate and adaptive immune reactions within the hepatic microenvironment [1, 5].
• The liver is a unique immunological organ where resident cells such as Kupffer cells, liver sinusoidal endothelial cells (LSECs), hepatic stellate cells, and natural killer T cells orchestrate tolerance and defense [4, 5].
• Hepatic immune responses are central to the pathogenesis of viral hepatitis, alcoholic and non-alcoholic fatty liver disease, ischemia/reperfusion injury, and hepatocellular carcinoma [1, 6, 8].
• Key signaling pathways include pattern recognition receptor signaling, cytokine production (e.g., TNF, IL-6, IL-1β), and chemokine-mediated leukocyte recruitment [1, 5].
• Experimental models for studying hepatic immune response include knockout mice, knock-in reporter lines, and CRISPR-based screens in hepatic cell lines [2, 3].
• Understanding hepatic immune response mechanisms is critical for developing immunotherapies for liver cancer and inflammatory liver diseases [2, 8].
Description
The liver is a vital organ with a unique immune microenvironment that balances tolerance to harmless antigens from the gut while mounting effective responses against pathogens. The Gene Ontology term GO:0002384, hepatic immune response, captures any immune response that takes place in the liver, including innate and adaptive immune reactions mediated by resident and recruited immune cells [1, 5]. This process is essential for host defense, but its dysregulation contributes to a wide range of liver diseases, from viral hepatitis to hepatocellular carcinoma [1, 8]. Researchers study hepatic immune response to understand mechanisms of liver inflammation, tolerance, and injury, and to identify therapeutic targets [4, 6]. The term encompasses diverse cellular and molecular events, such as cytokine signaling, antigen presentation, and leukocyte recruitment, which are orchestrated by liver-resident cells including Kupffer cells, liver sinusoidal endothelial cells (LSECs), and hepatic stellate cells [4, 5]. Given the liver's role in metabolism and detoxification, its immune responses are tightly regulated to avoid excessive tissue damage. This article provides a comprehensive overview of GO:0002384, covering its definition, key genes, research methods, and relevance to human disease, with a focus on CRISPR-based approaches for functional studies.
hepatic immune response At A Glance
| GO ID | GO:0002384 |
|---|---|
| GO term | hepatic immune response |
| Ontology | biological_process |
| Synonym | none |
| Major function | Immune response occurring in the liver, including innate and adaptive reactions |
| Related cellular components | Kupffer cells, liver sinusoidal endothelial cells, hepatic stellate cells, hepatocytes |
| Related molecular functions | Cytokine signaling, pattern recognition receptor activity, antigen presentation |
| Associated diseases | Viral hepatitis, non-alcoholic fatty liver disease, hepatocellular carcinoma, ischemia/reperfusion injury |
What Is GO:0002384?
According to the Gene Ontology, hepatic immune response (GO:0002384) is defined as an immune response taking place in the liver. This biological process includes any immune system reaction that occurs within the hepatic tissue, involving both innate and adaptive immunity. It encompasses the actions of liver-resident immune cells such as Kupffer cells and liver sinusoidal endothelial cells, as well as recruited immune cells, and the signaling molecules they produce [1, 4, 5].
Why Is hepatic immune response Important in Cell Biology?
Hepatic immune response is critically important because the liver is a major immunological organ that must maintain tolerance to gut-derived antigens while defending against pathogens. Dysregulation of this process leads to chronic inflammation, fibrosis, and cancer, making it a key area of research for understanding liver disease pathogenesis and developing new therapies [1, 8].
• The liver receives a large volume of blood from the gut and must discriminate between harmless antigens and pathogens, a function dependent on hepatic immune response.
• Kupffer cells, the resident liver macrophages, are key players in innate immune responses and produce inflammatory cytokines.
• Liver sinusoidal endothelial cells (LSECs) act as gatekeepers of hepatic immunity by scavenging antigens and presenting them to T cells.
• Hepatic immune responses contribute to the pathogenesis of alcoholic and non-alcoholic steatohepatitis [1, 8].
• Ischemia/reperfusion injury during liver surgery triggers sterile immune responses that can lead to organ damage.
• Chronic hepatitis B and C infections involve persistent hepatic immune responses that can progress to cirrhosis and hepatocellular carcinoma.
• The liver's immune microenvironment influences the efficacy of immunotherapies for liver cancer.
• Understanding hepatic immune response is essential for developing vaccines and treatments for liver diseases.
• CRISPR screening in hepatic cell models can identify novel regulators of hepatic immune response.
• Animal models with genetic modifications (knockout, knock-in) are invaluable for studying hepatic immune response in vivo.
What Happens During hepatic immune response?
Recognition of Pathogens and Danger Signals
In simple terms: The liver's immune cells detect invaders or damage using special sensors.
Hepatic immune response begins with the recognition of pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) by pattern recognition receptors (PRRs) on liver-resident cells such as Kupffer cells and LSECs [1, 5]. This recognition triggers intracellular signaling cascades that activate innate immune responses, including the production of pro-inflammatory cytokines and chemokines.
Activation of Innate Immune Cells
In simple terms: Resident immune cells in the liver become activated and start fighting.
Upon recognition of danger signals, Kupffer cells and other innate immune cells become activated, releasing cytokines such as TNF, IL-6, and IL-1β. These cytokines amplify the inflammatory response and recruit other immune cells to the liver. Natural killer (NK) cells and natural killer T (NKT) cells also become activated and can directly kill infected or transformed cells.
Recruitment of Circulating Immune Cells
In simple terms: Immune cells from the blood are called into the liver.
Chemokines produced by activated liver cells promote the recruitment of circulating leukocytes, including neutrophils, monocytes, and lymphocytes, into the liver [1, 5]. This recruitment is mediated by adhesion molecules on LSECs and integrins on leukocytes, facilitating their extravasation into the hepatic tissue.
Adaptive Immune Response and Antigen Presentation
In simple terms: The liver presents antigens to T cells to mount a specific attack.
LSECs and Kupffer cells can act as antigen-presenting cells, processing and presenting antigens to T cells. This leads to the activation of adaptive immune responses, including cytotoxic T cell responses against infected hepatocytes and helper T cell responses that further modulate the immune environment. The liver's unique microenvironment often favors tolerance, but under inflammatory conditions, effective adaptive immunity can be induced.
Resolution or Chronic Inflammation
In simple terms: The immune response either resolves or becomes long-lasting, causing damage.
After pathogen clearance, the hepatic immune response typically resolves through anti-inflammatory mechanisms and tissue repair. However, if the trigger persists (e.g., chronic viral infection or metabolic stress), the immune response can become chronic, leading to persistent inflammation, fibrosis, and eventually cirrhosis or hepatocellular carcinoma [1, 8].
Key Genes Involved in GO:0002384 hepatic immune response
The following genes and proteins are key players in hepatic immune response, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TLR4 | Pattern recognition receptor for LPS, activates innate immunity | Central to alcoholic liver disease and inflammation |
| MYD88 | Adaptor protein in TLR signaling | Mediates pro-inflammatory cytokine production in Kupffer cells |
| TNF | Pro-inflammatory cytokine | Drives hepatic inflammation and injury [1, 5] |
| IL6 | Cytokine involved in acute phase response and inflammation | Promotes liver regeneration and immune cell recruitment |
| IL1B | Pro-inflammatory cytokine | Contributes to liver damage in steatohepatitis [1, 8] |
| CCL2 | Chemokine that recruits monocytes | Key for macrophage infiltration in liver disease |
| CXCL10 | Chemokine for T cell recruitment | Involved in viral hepatitis and autoimmune liver disease |
| NFKB1 | Transcription factor regulating inflammatory genes | Master regulator of hepatic immune response |
| STAT3 | Transcription factor in cytokine signaling | Modulates inflammation and hepatocyte survival |
| NLRP3 | Inflammasome sensor | Activates IL-1β and IL-18 in liver inflammation |
| DDX3X | RNA helicase involved in innate immune signaling | Regulates interferon response in liver cells |
| IFNG | Cytokine produced by T and NK cells | Enhances antiviral and antitumor immunity in liver |
| CD8A | Marker of cytotoxic T cells | Mediates adaptive immune response against infected hepatocytes |
| FOXP3 | Transcription factor in regulatory T cells | Maintains immune tolerance in the liver |
| LY6C | Marker of inflammatory monocytes | Recruited to liver during injury |
| VCAM1 | Adhesion molecule on LSECs | Facilitates leukocyte recruitment |
| ICAM1 | Adhesion molecule on LSECs | Facilitates leukocyte adhesion and extravasation |
How Is hepatic immune response Regulated?
Hepatic immune response is tightly regulated by a network of cytokines, chemokines, and intracellular signaling pathways. Key regulatory mechanisms include the balance between pro-inflammatory and anti-inflammatory cytokines, such as TNF and IL-10, and the activity of transcription factors like NF-κB and STAT3 [1, 5]. The liver microenvironment also promotes tolerance through the action of regulatory T cells and immunosuppressive factors like TGF-β. Additionally, metabolic signals from the gut microbiome can modulate hepatic immune responses, as seen in non-alcoholic fatty liver disease.
hepatic immune response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TLR4 | Alcoholic liver disease, inflammation | TLR4 knockout mice |
| IL6 | Liver regeneration, inflammation | IL6 knockout mice |
| NLRP3 | Ischemia/reperfusion injury, NASH | NLRP3 knockout mice |
| DDX3X | Viral hepatitis, innate immunity | DDX3X knockout hepatic cell lines |
| FOXP3 | Autoimmune liver disease, tolerance | FOXP3 knock-in reporter mice |
Hepatic Immune Response in Viral Hepatitis
Chronic hepatitis B and C infections are characterized by persistent hepatic immune responses that fail to clear the virus, leading to chronic inflammation, fibrosis, and increased risk of hepatocellular carcinoma. The immune response involves both innate and adaptive arms, with cytotoxic T cells playing a key role in viral control but also contributing to liver damage.
Hepatic Immune Response in Non-Alcoholic Fatty Liver Disease (NAFLD)
NAFLD is characterized by the interplay between metabolism, microbes, and immunity. Hepatic immune responses driven by lipid accumulation and gut-derived signals promote inflammation and progression to non-alcoholic steatohepatitis (NASH) and fibrosis. Key players include Kupffer cells, inflammatory cytokines, and pattern recognition receptors [1, 8].
Hepatic Immune Response in Ischemia/Reperfusion Injury
Ischemia/reperfusion injury during liver surgery triggers a sterile immune response characterized by the release of DAMPs, activation of innate immune cells, and production of inflammatory cytokines. This response can lead to significant hepatocellular damage and organ dysfunction.
Hepatic Immune Response and Liver Cancer
The hepatic immune microenvironment plays a dual role in liver cancer, with immune surveillance capable of eliminating transformed cells but also chronic inflammation promoting tumorigenesis. Understanding these interactions is crucial for developing immunotherapies for hepatocellular carcinoma.
From hepatic immune response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Role of a specific gene in hepatic immune response | Knockout mouse or CRISPR knockout in hepatic cell line |
| Effect of a point mutation in an immune gene | Point mutation knock-in mouse or cell line |
| Tracking immune cell populations in liver | Knock-in reporter mouse (e.g., GFP-tagged cytokine) |
| Overexpression of a candidate immune regulator | Transgenic overexpression mouse or lentiviral overexpression in cells |
| High-throughput screening of immune regulators | CRISPR library screening in hepatic cell lines |
| Human-relevant hepatic immune response | Human liver organoids or primary hepatocytes |
How to Study the hepatic immune response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression | Identify immune response signatures in liver disease models |
| Flow cytometry | Immune cell populations and activation markers | Characterize liver immune infiltrates |
| ELISA/multiplex | Cytokine and chemokine levels | Quantify inflammation in serum or tissue |
| CRISPR knockout screening | Gene function loss-of-function | Discover regulators of hepatic immune response |
| CRISPR activation screening | Gene overexpression | Identify enhancers of immune response |
| Immunohistochemistry | Protein localization in tissue | Visualize immune cell infiltration in liver biopsies |
| Western blot | Protein expression and signaling | Validate pathways in hepatic cells |
Transcriptomic Analysis (RNA-seq)
RNA sequencing can profile gene expression changes in liver tissue or isolated hepatic cells during immune responses, identifying key pathways and biomarkers [1, 8].
Flow Cytometry and Immunophenotyping
Flow cytometry allows quantification and characterization of immune cell populations in the liver, including Kupffer cells, T cells, and NK cells, and their activation states.
Cytokine Profiling
Measuring cytokine levels (e.g., TNF, IL-6, IFN-γ) in serum or liver tissue using ELISA or multiplex assays provides insights into the inflammatory status.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens in hepatic cell lines can identify novel regulators of hepatic immune response pathways, such as cytokine production or pathogen restriction.
How CRISPR Can Be Used to Study GO:0002384 hepatic immune response
Knockout
CRISPR knockout of candidate genes in hepatic cell lines or mouse models can determine their necessity in hepatic immune response. For example, knocking out TLR4 or MYD88 in Kupffer cells can reveal their role in LPS-induced inflammation.
Point Mutation
Introducing specific point mutations (e.g., in kinase domains or binding sites) using CRISPR base editing or HDR can dissect the functional domains of immune signaling proteins without completely abolishing expression.
Knock-in
Knock-in of reporter genes (e.g., GFP) or epitope tags into endogenous loci allows real-time tracking of immune gene expression and protein localization in the liver.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can elevate the expression of immune regulators to study their sufficiency in driving hepatic immune responses.
How EDITGENE Supports hepatic immune response Research
Researchers studying hepatic immune response-related genes often need to determine whether a candidate gene is causally involved in the process. EDITGENE provides comprehensive CRISPR-based services to enable precise genetic modifications in hepatic cell models and animal models, accelerating discoveries in liver immunology.
Contact EDITGENE today to design your custom CRISPR model for hepatic immune response research.
Frequently Asked Questions About hepatic immune response
What is hepatic immune response?
Hepatic immune response (GO:0002384) is an immune response that takes place in the liver, involving both innate and adaptive immunity to defend against pathogens and maintain tissue homeostasis [1, 5].
What genes are involved in hepatic immune response?
Key genes include TLR4, MYD88, TNF, IL6, IL1B, CCL2, CXCL10, NFKB1, STAT3, NLRP3, DDX3X, IFNG, CD8A, FOXP3, and adhesion molecules like VCAM1 and ICAM1 [1, 3, 4, 5].
How is hepatic immune response studied?
It is studied using RNA-seq, flow cytometry, cytokine profiling, and CRISPR screening in hepatic cell lines and animal models [1, 3, 5].
What diseases are associated with hepatic immune response?
Diseases include viral hepatitis, non-alcoholic fatty liver disease, ischemia/reperfusion injury, and hepatocellular carcinoma [1, 6, 8].
What are Kupffer cells?
Kupffer cells are resident liver macrophages that play a central role in innate immune responses in the liver.
What is the role of liver sinusoidal endothelial cells (LSECs) in immunity?
LSECs act as gatekeepers of hepatic immunity by scavenging antigens, presenting them to T cells, and regulating leukocyte recruitment.
How does CRISPR help study hepatic immune response?
CRISPR enables knockout, knock-in, point mutation, and overexpression of genes in hepatic cells, allowing functional dissection of immune pathways.
What is the role of cytokines in hepatic immune response?
Cytokines such as TNF, IL-6, and IFN-γ orchestrate inflammation, immune cell recruitment, and pathogen clearance in the liver [1, 5].
Can hepatic immune response be modulated therapeutically?
Yes, targeting immune pathways is a promising strategy for treating liver diseases, including immunotherapies for liver cancer [2, 8].
What is the difference between hepatic immune response and systemic immune response?
Hepatic immune response is localized to the liver and involves unique resident cells and tolerance mechanisms, while systemic immune response occurs throughout the body.
Conclusion
GO:0002384 hepatic immune response is a fundamental biological process that governs liver defense and homeostasis. Its dysregulation underlies major liver diseases, making it a critical area of research. Advances in CRISPR-based models and screening technologies are accelerating the discovery of new therapeutic targets. EDITGENE provides essential tools to study hepatic immune response with precision and scale.
References
- 1. Szabo G et al.. 2007. Innate immune response and hepatic inflammation.. Semin Liver Dis 27(4):339-50 PMID: 17979071
- 2. Maiorino L et al.. 2022. Innate Immunity and Cancer Pathophysiology.. Annu Rev Pathol 17:425-457 PMID: 34788549
- 3. Mo J et al.. 2021. DDX3X: structure, physiologic functions and cancer.. Mol Cancer 20(1):38 PMID: 33627125
- 4. Shetty S et al.. 2018. Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity.. Nat Rev Gastroenterol Hepatol 15(9):555-567 PMID: 29844586
- 5. Heymann F et al.. 2016. Immunology in the liver--from homeostasis to disease.. Nat Rev Gastroenterol Hepatol 13(2):88-110 PMID: 26758786
- 6. van Golen RF et al.. 2012. The sterile immune response during hepatic ischemia/reperfusion.. Cytokine Growth Factor Rev 23(3):69-84 PMID: 22609105
- 8. Tilg H et al.. 2021. Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity.. Nat Metab 3(12):1596-1607 PMID: 34931080
